NOVO.B.DK

300.75

-1.72%↓

HLUNB.DK

39.24

-2.49%↓

AMBUB.DK

81.15

+1.25%↑

NOVO.B.DK

300.75

-1.72%↓

HLUNB.DK

39.24

-2.49%↓

AMBUB.DK

81.15

+1.25%↑

NOVO.B.DK

300.75

-1.72%↓

HLUNB.DK

39.24

-2.49%↓

AMBUB.DK

81.15

+1.25%↑

NOVO.B.DK

300.75

-1.72%↓

HLUNB.DK

39.24

-2.49%↓

AMBUB.DK

81.15

+1.25%↑

NOVO.B.DK

300.75

-1.72%↓

HLUNB.DK

39.24

-2.49%↓

AMBUB.DK

81.15

+1.25%↑

Search

Coloplast A-S (Class B)

Închisă

482.4 0.48

Rezumat

Modificarea prețului

24h

Curent

Minim

481.5

Maxim

487

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

27.421

110.024

EPS

6.32

Randament dividend

4.84

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.84%

2.26%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-9.1B

110B

Deschiderea anterioară

481.92

Închiderea anterioară

482.4

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

20 feb. 2026, 17:37 UTC

Achiziții, Fuziuni, Preluări

Paramount Regulatory Waiting Period for Warner Bid Expires -- Update

21 feb. 2026, 14:31 UTC

Achiziții, Fuziuni, Preluări

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20 feb. 2026, 23:12 UTC

Achiziții, Fuziuni, Preluări

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 feb. 2026, 22:12 UTC

Câștiguri

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20 feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20 feb. 2026, 21:23 UTC

Câștiguri

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 feb. 2026, 21:01 UTC

Achiziții, Fuziuni, Preluări

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

20 feb. 2026, 20:17 UTC

Market Talk

Oil Futures Mixed As Market Awaits U.S.-Iran Moves -- Market Talk

20 feb. 2026, 20:11 UTC

Market Talk

Traders Await Word on USMCA Exemption For Trump's Global 10% Tariff -- Market Talk

20 feb. 2026, 19:59 UTC

Market Talk

U.S. Tariff Ruling Could Make Things Worse for Mexico -- Market Talk

20 feb. 2026, 19:58 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Seen as Not Needing Warner Bros. Deal -- Market Talk

20 feb. 2026, 19:49 UTC

Market Talk

Mexico's Revised 4Q GDP Expected to Confirm Pick-Up -- Market Talk

20 feb. 2026, 19:09 UTC

Market Talk

Precious Metals Settle Higher After Tariff Ruling -- Market Talk

20 feb. 2026, 19:00 UTC

Market Talk

U.S. Oil, Gas Rig Counts Unchanged on Week -- Market Talk

20 feb. 2026, 18:28 UTC

Market Talk

Ontario Premier Warns Fight Against U.S. Tariffs Isn't Over -- Market Talk

20 feb. 2026, 18:20 UTC

Market Talk

Tariff Ruling Seen Positive for Some Retailers, Mixed for Others -- Market Talk

20 feb. 2026, 18:05 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 feb. 2026, 18:04 UTC

Market Talk

Trade Uncertainty in Canada to Remain Until USMCA Resolved -- Market Talk

20 feb. 2026, 17:38 UTC

Market Talk

Canada's Small Firms Look Toward Increased U.S. Tariff Opposition -- Market Talk

20 feb. 2026, 17:24 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 feb. 2026, 17:24 UTC

Market Talk

Correction to Treasury Yields Fall Market Talk

20 feb. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

20 feb. 2026, 16:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

20 feb. 2026, 16:53 UTC

Market Talk

Canada Dollar Steady, Market Focus on USMCA Review -- Market Talk

20 feb. 2026, 16:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 feb. 2026, 16:45 UTC

Market Talk

U.K. Public Finances Supportive of Gilts in Near-Term -- Market Talk

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat